aluates Reports

$ 0.0

Automative

Global Norovirus Diagnostics Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-17D13067

Global Norovirus Diagnostics Market Research Report 2023

BUY CHAPTERS

Global Norovirus Diagnostics Market Research Report 2025

Code: QYRE-Auto-17D13067

Report

May 2025

Pages:71

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott

R-Biopharm

ELITechGroup

Danaher Corporation (Cepheid)

Meridian Bioscience

Eiken Chemical

Altona Diagnostics

Certest Biotec

Elisabeth Pharmacon

Qiagen NV

Norovirus Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Norovirus Diagnostics Market

The global market for Norovirus Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Norovirus diagnostics refer to the methods and procedures used to identify the presence of norovirus in clinical samples, environmental samples, or food samples. Norovirus is a highly contagious virus that causes acute gastroenteritis in humans. It is a common cause of outbreaks of vomiting and diarrhea, particularly in settings such as cruise ships, healthcare facilities, and restaurants.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Norovirus Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Norovirus Diagnostics.

The Norovirus Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Norovirus Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Norovirus Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Norovirus Diagnostics Market Report

Report Metric	Details
Report Name	Norovirus Diagnostics Market
CAGR	5%
Segment by Type	Rapid Test Kits PCR Kits ELISA Based Kits
Segment by Application	Hospitals Diagnostics Labs Clinics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, R-Biopharm, ELITechGroup, Danaher Corporation (Cepheid), Meridian Bioscience, Eiken Chemical, Altona Diagnostics, CerTest Biotec, Elisabeth Pharmacon, Qiagen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Norovirus Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Norovirus Diagnostics Market report?

Ans: The main players in the Norovirus Diagnostics Market are Abbott, R-Biopharm, ELITechGroup, Danaher Corporation (Cepheid), Meridian Bioscience, Eiken Chemical, Altona Diagnostics, CerTest Biotec, Elisabeth Pharmacon, Qiagen

What are the Application segmentation covered in the Norovirus Diagnostics Market report?

Ans: The Applications covered in the Norovirus Diagnostics Market report are Hospitals, Diagnostics Labs, Clinics

What are the Type segmentation covered in the Norovirus Diagnostics Market report?

Ans: The Types covered in the Norovirus Diagnostics Market report are Rapid Test Kits, PCR Kits, ELISA Based Kits

Recommended Reports

Diagnostic Market Trends

Infectious Disease Testing

Gastroenteric & Viral Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Norovirus Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Rapid Test Kits

1.2.3 PCR Kits

1.2.4 ELISA Based Kits

1.3 Market by Application

1.3.1 Global Norovirus Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Diagnostics Labs

1.3.4 Clinics

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Norovirus Diagnostics Market Perspective (2020-2031)

2.2 Global Norovirus Diagnostics Growth Trends by Region

2.2.1 Global Norovirus Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Norovirus Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 Norovirus Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 Norovirus Diagnostics Market Dynamics

2.3.1 Norovirus Diagnostics Industry Trends

2.3.2 Norovirus Diagnostics Market Drivers

2.3.3 Norovirus Diagnostics Market Challenges

2.3.4 Norovirus Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Norovirus Diagnostics Players by Revenue

3.1.1 Global Top Norovirus Diagnostics Players by Revenue (2020-2025)

3.1.2 Global Norovirus Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Norovirus Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Norovirus Diagnostics Revenue

3.4 Global Norovirus Diagnostics Market Concentration Ratio

3.4.1 Global Norovirus Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Norovirus Diagnostics Revenue in 2024

3.5 Global Key Players of Norovirus Diagnostics Head office and Area Served

3.6 Global Key Players of Norovirus Diagnostics, Product and Application

3.7 Global Key Players of Norovirus Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Norovirus Diagnostics Breakdown Data by Type

4.1 Global Norovirus Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Norovirus Diagnostics Forecasted Market Size by Type (2026-2031)

5 Norovirus Diagnostics Breakdown Data by Application

5.1 Global Norovirus Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Norovirus Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Norovirus Diagnostics Market Size (2020-2031)

6.2 North America Norovirus Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Norovirus Diagnostics Market Size by Country (2020-2025)

6.4 North America Norovirus Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Norovirus Diagnostics Market Size (2020-2031)

7.2 Europe Norovirus Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Norovirus Diagnostics Market Size by Country (2020-2025)

7.4 Europe Norovirus Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Norovirus Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific Norovirus Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Norovirus Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Norovirus Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Norovirus Diagnostics Market Size (2020-2031)

9.2 Latin America Norovirus Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Norovirus Diagnostics Market Size by Country (2020-2025)

9.4 Latin America Norovirus Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Norovirus Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa Norovirus Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Norovirus Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Norovirus Diagnostics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Norovirus Diagnostics Introduction

11.1.4 Abbott Revenue in Norovirus Diagnostics Business (2020-2025)

11.1.5 Abbott Recent Development

11.2 R-Biopharm

11.2.1 R-Biopharm Company Details

11.2.2 R-Biopharm Business Overview

11.2.3 R-Biopharm Norovirus Diagnostics Introduction

11.2.4 R-Biopharm Revenue in Norovirus Diagnostics Business (2020-2025)

11.2.5 R-Biopharm Recent Development

11.3 ELITechGroup

11.3.1 ELITechGroup Company Details

11.3.2 ELITechGroup Business Overview

11.3.3 ELITechGroup Norovirus Diagnostics Introduction

11.3.4 ELITechGroup Revenue in Norovirus Diagnostics Business (2020-2025)

11.3.5 ELITechGroup Recent Development

11.4 Danaher Corporation (Cepheid)

11.4.1 Danaher Corporation (Cepheid) Company Details

11.4.2 Danaher Corporation (Cepheid) Business Overview

11.4.3 Danaher Corporation (Cepheid) Norovirus Diagnostics Introduction

11.4.4 Danaher Corporation (Cepheid) Revenue in Norovirus Diagnostics Business (2020-2025)

11.4.5 Danaher Corporation (Cepheid) Recent Development

11.5 Meridian Bioscience

11.5.1 Meridian Bioscience Company Details

11.5.2 Meridian Bioscience Business Overview

11.5.3 Meridian Bioscience Norovirus Diagnostics Introduction

11.5.4 Meridian Bioscience Revenue in Norovirus Diagnostics Business (2020-2025)

11.5.5 Meridian Bioscience Recent Development

11.6 Eiken Chemical

11.6.1 Eiken Chemical Company Details

11.6.2 Eiken Chemical Business Overview

11.6.3 Eiken Chemical Norovirus Diagnostics Introduction

11.6.4 Eiken Chemical Revenue in Norovirus Diagnostics Business (2020-2025)

11.6.5 Eiken Chemical Recent Development

11.7 Altona Diagnostics

11.7.1 Altona Diagnostics Company Details

11.7.2 Altona Diagnostics Business Overview

11.7.3 Altona Diagnostics Norovirus Diagnostics Introduction

11.7.4 Altona Diagnostics Revenue in Norovirus Diagnostics Business (2020-2025)

11.7.5 Altona Diagnostics Recent Development

11.8 CerTest Biotec

11.8.1 CerTest Biotec Company Details

11.8.2 CerTest Biotec Business Overview

11.8.3 CerTest Biotec Norovirus Diagnostics Introduction

11.8.4 CerTest Biotec Revenue in Norovirus Diagnostics Business (2020-2025)

11.8.5 CerTest Biotec Recent Development

11.9 Elisabeth Pharmacon

11.9.1 Elisabeth Pharmacon Company Details

11.9.2 Elisabeth Pharmacon Business Overview

11.9.3 Elisabeth Pharmacon Norovirus Diagnostics Introduction

11.9.4 Elisabeth Pharmacon Revenue in Norovirus Diagnostics Business (2020-2025)

11.9.5 Elisabeth Pharmacon Recent Development

11.10 Qiagen

11.10.1 Qiagen Company Details

11.10.2 Qiagen Business Overview

11.10.3 Qiagen Norovirus Diagnostics Introduction

11.10.4 Qiagen Revenue in Norovirus Diagnostics Business (2020-2025)

11.10.5 Qiagen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott

R-Biopharm

ELITechGroup

Danaher Corporation (Cepheid)

Meridian Bioscience

Eiken Chemical

Altona Diagnostics

Certest Biotec

Elisabeth Pharmacon

Qiagen NV

List of Tables

Table 1. Global Norovirus Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Rapid Test Kits

Table 3. Key Players of PCR Kits

Table 4. Key Players of ELISA Based Kits

Table 5. Global Norovirus Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Norovirus Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Norovirus Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Norovirus Diagnostics Market Share by Region (2020-2025)

Table 9. Global Norovirus Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Norovirus Diagnostics Market Share by Region (2026-2031)

Table 11. Norovirus Diagnostics Market Trends

Table 12. Norovirus Diagnostics Market Drivers

Table 13. Norovirus Diagnostics Market Challenges

Table 14. Norovirus Diagnostics Market Restraints

Table 15. Global Norovirus Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Norovirus Diagnostics Market Share by Players (2020-2025)

Table 17. Global Top Norovirus Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Norovirus Diagnostics as of 2024)

Table 18. Ranking of Global Top Norovirus Diagnostics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Norovirus Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Norovirus Diagnostics, Headquarters and Area Served

Table 21. Global Key Players of Norovirus Diagnostics, Product and Application

Table 22. Global Key Players of Norovirus Diagnostics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Norovirus Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Norovirus Diagnostics Revenue Market Share by Type (2020-2025)

Table 26. Global Norovirus Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Norovirus Diagnostics Revenue Market Share by Type (2026-2031)

Table 28. Global Norovirus Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Norovirus Diagnostics Revenue Market Share by Application (2020-2025)

Table 30. Global Norovirus Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Norovirus Diagnostics Revenue Market Share by Application (2026-2031)

Table 32. North America Norovirus Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Norovirus Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Norovirus Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Norovirus Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Norovirus Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Norovirus Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Norovirus Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Norovirus Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Norovirus Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Norovirus Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Norovirus Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Norovirus Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Norovirus Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Norovirus Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Norovirus Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Abbott Company Details

Table 48. Abbott Business Overview

Table 49. Abbott Norovirus Diagnostics Product

Table 50. Abbott Revenue in Norovirus Diagnostics Business (2020-2025) & (US$ Million)

Table 51. Abbott Recent Development

Table 52. R-Biopharm Company Details

Table 53. R-Biopharm Business Overview

Table 54. R-Biopharm Norovirus Diagnostics Product

Table 55. R-Biopharm Revenue in Norovirus Diagnostics Business (2020-2025) & (US$ Million)

Table 56. R-Biopharm Recent Development

Table 57. ELITechGroup Company Details

Table 58. ELITechGroup Business Overview

Table 59. ELITechGroup Norovirus Diagnostics Product

Table 60. ELITechGroup Revenue in Norovirus Diagnostics Business (2020-2025) & (US$ Million)

Table 61. ELITechGroup Recent Development

Table 62. Danaher Corporation (Cepheid) Company Details

Table 63. Danaher Corporation (Cepheid) Business Overview

Table 64. Danaher Corporation (Cepheid) Norovirus Diagnostics Product

Table 65. Danaher Corporation (Cepheid) Revenue in Norovirus Diagnostics Business (2020-2025) & (US$ Million)

Table 66. Danaher Corporation (Cepheid) Recent Development

Table 67. Meridian Bioscience Company Details

Table 68. Meridian Bioscience Business Overview

Table 69. Meridian Bioscience Norovirus Diagnostics Product

Table 70. Meridian Bioscience Revenue in Norovirus Diagnostics Business (2020-2025) & (US$ Million)

Table 71. Meridian Bioscience Recent Development

Table 72. Eiken Chemical Company Details

Table 73. Eiken Chemical Business Overview

Table 74. Eiken Chemical Norovirus Diagnostics Product

Table 75. Eiken Chemical Revenue in Norovirus Diagnostics Business (2020-2025) & (US$ Million)

Table 76. Eiken Chemical Recent Development

Table 77. Altona Diagnostics Company Details

Table 78. Altona Diagnostics Business Overview

Table 79. Altona Diagnostics Norovirus Diagnostics Product

Table 80. Altona Diagnostics Revenue in Norovirus Diagnostics Business (2020-2025) & (US$ Million)

Table 81. Altona Diagnostics Recent Development

Table 82. CerTest Biotec Company Details

Table 83. CerTest Biotec Business Overview

Table 84. CerTest Biotec Norovirus Diagnostics Product

Table 85. CerTest Biotec Revenue in Norovirus Diagnostics Business (2020-2025) & (US$ Million)

Table 86. CerTest Biotec Recent Development

Table 87. Elisabeth Pharmacon Company Details

Table 88. Elisabeth Pharmacon Business Overview

Table 89. Elisabeth Pharmacon Norovirus Diagnostics Product

Table 90. Elisabeth Pharmacon Revenue in Norovirus Diagnostics Business (2020-2025) & (US$ Million)

Table 91. Elisabeth Pharmacon Recent Development

Table 92. Qiagen Company Details

Table 93. Qiagen Business Overview

Table 94. Qiagen Norovirus Diagnostics Product

Table 95. Qiagen Revenue in Norovirus Diagnostics Business (2020-2025) & (US$ Million)

Table 96. Qiagen Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

Table 100. Authors List of This Report

List of Figures

Figure 1. Norovirus Diagnostics Picture

Figure 2. Global Norovirus Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Norovirus Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. Rapid Test Kits Features

Figure 5. PCR Kits Features

Figure 6. ELISA Based Kits Features

Figure 7. Global Norovirus Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Norovirus Diagnostics Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Diagnostics Labs Case Studies

Figure 11. Clinics Case Studies

Figure 12. Norovirus Diagnostics Report Years Considered

Figure 13. Global Norovirus Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Norovirus Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Norovirus Diagnostics Market Share by Region: 2024 VS 2031

Figure 16. Global Norovirus Diagnostics Market Share by Players in 2024

Figure 17. Global Top Norovirus Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Norovirus Diagnostics as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Norovirus Diagnostics Revenue in 2024

Figure 19. North America Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Norovirus Diagnostics Market Share by Country (2020-2031)

Figure 21. United States Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Norovirus Diagnostics Market Share by Country (2020-2031)

Figure 25. Germany Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Norovirus Diagnostics Market Share by Region (2020-2031)

Figure 33. China Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Norovirus Diagnostics Market Share by Country (2020-2031)

Figure 41. Mexico Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Norovirus Diagnostics Market Share by Country (2020-2031)

Figure 45. Turkey Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Norovirus Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Abbott Revenue Growth Rate in Norovirus Diagnostics Business (2020-2025)

Figure 49. R-Biopharm Revenue Growth Rate in Norovirus Diagnostics Business (2020-2025)

Figure 50. ELITechGroup Revenue Growth Rate in Norovirus Diagnostics Business (2020-2025)

Figure 51. Danaher Corporation (Cepheid) Revenue Growth Rate in Norovirus Diagnostics Business (2020-2025)

Figure 52. Meridian Bioscience Revenue Growth Rate in Norovirus Diagnostics Business (2020-2025)

Figure 53. Eiken Chemical Revenue Growth Rate in Norovirus Diagnostics Business (2020-2025)

Figure 54. Altona Diagnostics Revenue Growth Rate in Norovirus Diagnostics Business (2020-2025)

Figure 55. CerTest Biotec Revenue Growth Rate in Norovirus Diagnostics Business (2020-2025)

Figure 56. Elisabeth Pharmacon Revenue Growth Rate in Norovirus Diagnostics Business (2020-2025)

Figure 57. Qiagen Revenue Growth Rate in Norovirus Diagnostics Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Infectious Disease Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Virus Testing Diagnostic Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Adenovirus Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hepatitis Viruses Diagnostic Tests Market Research Report 2024

Rapid Virus Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infectious Disease In vitro Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Covid 19 Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Poultry Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rapid Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Respiratory Infection Diagnostic Market Research Report 2024

Coronavirus Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Livestock Diagnostics Kits Market Insights Forecast to 2030

COVID 19 Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infectious Disease Rapid Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liver Cancer Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibiotic Resistance Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Infectious Respiratory Disease Diagnostics Market Research Report 2025

Global Diagnostic Guidewire Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions